Fmoc-Val-Cit-PAB-OH
159858-22-7
|
Fmoc-Val-Cit-PAB-PNP
863971-53-3
|
Fmoc-Val-Cit-PAB-PNP
208247-83-0
|
Fmoc-Val-Cit-PAB-MMAE
1350456-56-2
|
Fmoc-Val-D-Cit-PAB
1350456-67-5
|
Fmoc-Val-Cit-OH
159858-21-6
|
Fmoc-D-Val-Cit-PAB
1350456-65-3
|
Fmoc-Gly3-Val-Cit-PAB
2647914-09-6
|
Fmoc-Cit-PAB-OH
870487-04-0
|
4-((Cyclohexylamino)methyl)benzoic acid hydrochloride
1158522-08-7
|
1-[(2,4-Dichlorophenyl)methyl]-N-(1,1-dimethylethyl)-2-methyl-1H-indole-3-methanamine
940364-43-2
|
2-Methoxy-6-(pyrazol-1-yl)-benzonitrile
134104-43-1
|
2-methoxy-4,5-dimethyl-N-(2-oxoindolin-5-yl)benzenesulfonamide
921836-56-8
|
1H-3-Benzazepin-7-ol, 8-chloro-2,3,4,5-tetrahydro-5-(3-iodophenyl)-3-methyl-, (S)-
131615-57-1
|
2-oxo-2-(1-(2-oxo-2-(piperidin-1-yl)ethyl)-1H-indol-3-yl)-N-(3,3,5-trimethylcyclohexyl)acetamide
872861-15-9
|
(4-Methyl-tetrahydro-furan-2-yl)-methanol
6906-52-1
|
(2S)-3-{[tert-butyl(diphenyl)silyl]oxy}-2-methyl-1-propanol
120346-83-0
|
N-(1-cyanocyclopentyl)-2-[4-(4-fluorobenzenesulfonyl)-1,4-diazepan-1-yl]acetamide
930439-75-1
|
4,5,6,7-Tetrahydrobenzo[d]isoxazole-3-carbaldehyde
1018584-77-4
|
